CASI Pharmaceuticals Inc (NASDAQ:CASI)
| 3.05 Delayed Data As of 3:35pm ET |  +0.09 / +3.04%Today’s Change | 2.87 Today|||52-Week Range 17.40 | -61.87% Year-to-Date |
Latest CASI News | Press Releases
No recent news for CASI Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.96 |
| Today’s open | 3.05 |
| Day’s range | 2.99 - 3.05 |
| Volume | 26 |
| Average volume (3 months) | 60,105 |
| Market cap | $42.2M |
Data as of 3:35pm ET, 06/27/2022
Growth & Valuation
| Earnings growth (last year) | +38.40% |
| Earnings growth (this year) | -38.27% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +100.12% |
| P/E ratio | NM |
| Price/Sales | 3.63 |
| Price/Book | 0.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACSTAcasti Pharma Inc | -0.01 | -0.56% |
| AIMAIM ImmunoTech Inc | +0.03 | +3.57% |
| NYMXNymox Pharmaceutical... | +0.02 | +3.70% |
| CRVSCorvus Pharmaceutica... | +0.23 | +26.94% |
Data as of 3:59pm ET, 06/27/2022
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$2.40 |
| Annual revenue (last year) | $30.0M |
| Annual profit (last year) | -$36.7M |
| Net profit margin | -122.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
